Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain

Annals of Anatomy

Volumn 195, Issue 5, 2013, Pages 415-423

  Azami Tameh, Abolfazl ^a,b   Clarner, Tim ^b   Beyer, Cordian ^b   Atlasi, Mohammad Ali ^a   Hassanzadeh, Gholamreza ^c   Naderian, Homayoun ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cuprizone; Demyelination; Glutamate receptor; Glutamate transporter; MS

Indexed keywords

CUPRIZONE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; NEUROTOXIN; PROTEIN SLC1A4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; DISEASE EXACERBATION; GRAY MATTER; MALE; MOUSE; MULTIPLE SCLEROSIS; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; TELENCEPHALON; TISSUE STRUCTURE; WHITE MATTER;

AMPA; BOVINE SERUM ALBUMIN; BSA; CC; CENTRAL NERVOUS SYSTEM; CNS; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATION; EAAT; EAE; ECL; ENHANCED CHEMILUMINESCENCE; EXCITATORY AMINO ACID TRANSPORTER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GFAP; GLAST; GLIAL FIBRILLARY ACIDIC PROTEIN; GLT; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR, IONOTROPIC AMPA; GLUTAMATE RECEPTOR, METABOTROPIC; GLUTAMATE TRANSPORTER; GLUTAMATE-ASPARTATE TRANSPORTER; GRIA; GRM; HORSERADISH PEROXIDASE; HPRT; HRP; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; IBA; IHC; IMMUNOHISTOCHEMISTRY; IONIZED CALCIUM-BINDING ADAPTOR MOLECULE; MAPK; MBP; METABOTROPIC GLUTAMATE RECEPTORS; MGLURS; MITOGEN-ACTIVATED PROTEIN KINASE; MOG; MS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N-METHYL-D-ASPARTATE; NITRIC OXIDE; NMDA; NO; PBS; PHOSPHATE-BUFFERED SALINE; PLP; POLYVINYLIDENFLUORIDE; PROTEOLIPID PROTEIN; PVDF; SDS; SLC; SODIUM DODECYLSULFATE; SOLUTE CARRIER; TGF-Β1; TRANSFORMING GROWTH FACTOR-BETA 1; Α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; CHELATING AGENTS; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; FLUORESCENT ANTIBODY TECHNIQUE; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PROTEIN ARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 84887206057     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2013.03.004     Document Type: Article

References (59)

1. Arranz A.M., Hussein A., Alix J.J., Perez-Cerda F., Allcock N., Matute C., Fern R. Functional glutamate transport in rodent optic nerve axons and glia. Glia 2008, 56:1353-1367.
2. Baertling F., Kokozidou M., Pufe T., Clarner T., Windoffer R., Wruck C.J., Brandenburg L.O., Beyer C., Kipp M. ADAM12 is expressed by astrocytes during experimental demyelination. Brain Res. 2010, 1326:1-14.
3. Basso A.S., Frenkel D., Quintana F.J., Costa-Pinto F.A., Petrovic-Stojkovic S., Puckett L., Monsonego A., Bar-Shir A., Engel Y., Gozin M., Weiner H.L. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest. 2008, 118:1532-1543.
4. Batoulis H., Addicks K., Kuerten S. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm. Ann. Anat. 2010, 192:179-193.
5. Besancon E., Guo S., Lok J., Tymianski M., Lo E.H. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol. Sci. 2008, 29:268-275.
6. Blakemore W.F., Franklin R.J. Remyelination in experimental models of toxin-induced demyelination. Curr. Top. Microbiol. Immunol. 2008, 318:193-212.
7. Bolton C., Paul C. Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm. 2006, 93684.
8. Caraci F., Battaglia G., Sortino M.A., Spampinato S., Molinaro G., Copani A., Nicoletti F., Bruno V. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?. Neurochem. Int. 2012, 61:559-565.
9. Daniels R.W., Miller B.R., DiAntonio A. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration. Neurobiol. Dis. 2011, 41:415-420.
10. Deng W., Wang H., Rosenberg P.A., Volpe J.J., Jensen F.E. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7751-7756.
11. Featherstone D.E. Glial solute carrier transporters in Drosophila and mice. Glia 2011, 59:1351-1363.
12. Friese M.A., Montalban X., Willcox N., Bell J.I., Martin R., Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 2006, 129:1940-1952.
13. Gegelashvili G., Schousboe A. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull. 1998, 45:233-238.
14. Geurts J.J., Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008, 7:841-851.
15. Geurts J.J., Wolswijk G., Bo L., van der Valk P., Polman C.H., Troost D., Aronica E. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 2003, 126:1755-1766.
16. Geurts J.J., Wolswijk G., Bo L., Redeker S., Ramkema M., Troost D., Aronica E. Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J. Neuroimmunol. 2005, 158:182-190.
17. Groebe A., Clarner T., Baumgartner W., Dang J., Beyer C., Kipp M. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 2009, 8:163-174.
18. Hamby M.E., Sofroniew M.V. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 2010, 7:494-506.
19. Huang K., Kang M.H., Askew C., Kang R., Sanders S.S., Wan J., Davis N.G., Hayden M.R. Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol. Dis. 2010, 40:207-215.
20. Johann S., Kampmann E., Denecke B., Arnold S., Kipp M., Mey J., Beyer C. Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J. Mol. Neurosci. 2008, 34:177-185.
21. Kanai Y., Hediger M.A. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflug. Arch. 2004, 447:469-479.
22. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
23. Ketheeswaranathan P., Turner N.A., Spary E.J., Batten T.F., McColl B.W., Saha S. Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia. Brain Res. 2011, 1418:93-103.
24. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., Reed J.C., Stebbins J.L., Pellecchia M., Sarkar D., Fisher P.B. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell Physiol. 2011, 226:2484-2493.
25. Kipp M., Clarner T., Dang J., Copray S., Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009, 118:723-736.
26. Kuerten S., Angelov D.N. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis. Ann. Anat. 2008, 190:1-15.
27. Lang M., Wang L., Fan Q., Xiao G., Wang X., Zhong Y., Zhou B. Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates a beta pathology in a Drosophila model of Alzheimer's disease. PLoS Genet. 2012, 8:e1002683.
28. Lassmann H. Experimental models of multiple sclerosis. Rev. Neurol. (Paris) 2007, 163:651-655.
29. Lee H.G., Zhu X., Casadesus G., Pallas M., Camins A., O'Neill M.J., Nakanishi S., Perry G., Smith M.A. The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival. Brain Res. 2009, 1249:244-250.
30. Li S., Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 2000, 20:1190-1198.
31. Lindahl J.S., Kjellsen B.R., Tigert J., Miskimins R. In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex. Brain Res. 2008, 1234:137-147.
32. Lorenz L., Dang J., Misiak M., Tameh Abolfazl A., Beyer C., Kipp M. Combined 17beta-oestradiol and progesterone treatment prevents neuronal cell injury in cortical but not midbrain neurones or neuroblastoma cells. J. Neuroendocrinol. 2009, 21:841-849.
33. Maragakis N.J., Dietrich J., Wong V., Xue H., Mayer-Proschel M., Rao M.S., Rothstein J.D. Glutamate transporter expression and function in human glial progenitors. Glia 2004, 45:133-143.
34. Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 2004, 55:469-477.
35. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 1996, 40:759-766.
36. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
37. Matteucci A., Cammarota R., Paradisi S., Varano M., Balduzzi M., Leo L., Bellenchi G.C., De Nuccio C., Carnovale-Scalzo G., Scorcia G., Frank C., Mallozzi C., Di Stasi A.M., Visentin S., Malchiodi-Albedi F. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Invest. Ophthalmol. Vis. Sci. 2011, 52:1070-1077.
38. Mennerick S., Dhond R.P., Benz A., Xu W., Rothstein J.D., Danbolt N.C., Isenberg K.E., Zorumski C.F. Neuronal expression of the glutamate transporter GLT-1 in hippocampal microcultures. J. Neurosci. 1998, 18:4490-4499.
39. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
40. Nakanishi H., Zhang J., Koike M., Nishioku T., Okamoto Y., Kominami E., von Figura K., Peters C., Yamamoto K., Saftig P., Uchiyama Y. Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J. Neurosci. 2001, 21:7526-7533.
41. Newcombe J., Uddin A., Dove R., Patel B., Turski L., Nishizawa Y., Smith T. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol. 2008, 18:52-61.
42. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., Mantelli B., Bronte V., Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2007, 212:795-812.
43. Peters C., Lotzerich H., Raabe-Oekter A., Mucha C., Michna H. Functional activity of immune cells in female MS-patients. Ann. Anat. 1998, 180:321-325.
44. Phillis J.W., Ren J., O'Regan M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with dl-threo-beta-benzyloxyaspartate. Brain Res. 2000, 868:105-112.
45. Pott F., Gingele S., Clarner T., Dang J., Baumgartner W., Beyer C., Kipp M. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia. Brain Res. 2009, 1305:137-149.
46. Rattray M., Bendotti C. Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?. Exp. Neurol. 2006, 201:15-23.
47. Ritter S.L., Asay M.J., Paquet M., Paavola K.J., Reiff R.E., Yun C.C., Hall R.A. GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2. Neurosci. Lett. 2011, 487:3-7.
48. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 1984, 4:1884-1891.
49. Schuettauf F., Thaler S., Bolz S., Fries J., Kalbacher H., Mankowska A., Zurakowski D., Zrenner E., Rejdak R. Alterations of amino acids and glutamate transport in the DBA/2J mouse retina; possible clues to degeneration. Graef. Arch. Clin. Exp. Ophthalmol. 2007, 245:1157-1168.
50. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
51. Shijie J., Takeuchi H., Yawata I., Harada Y., Sonobe Y., Doi Y., Liang J., Hua L., Yasuoka S., Zhou Y., Noda M., Kawanokuchi J., Mizuno T., Suzumura A. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. Tohoku J. Exp. Med. 2009, 217:87-92.
52. Shobha K., Vijayalakshmi K., Alladi P.A., Nalini A., Sathyaprabha T.N., Raju T.R. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J. Neurol. Sci. 2007, 254:9-16.
53. Skripuletz T., Hackstette D., Bauer K., Gudi V., Pul R., Voss E., Berger K., Kipp M., Baumgartner W., Stangel M. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 2013, 136:147-167.
54. Storck T., Schulte S., Hofmann K., Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10955-10959.
55. Takasaki C., Yamasaki M., Uchigashima M., Konno K., Yanagawa Y., Watanabe M. Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex. Eur. J. Neurosci. 2010, 32:1326-1336.
56. Torkildsen O., Brunborg L.A., Myhr K.M., Bo L. The cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 2008, 188:72-76.
57. Vallejo-Illarramendi A., Domercq M., Perez-Cerda F., Ravid R., Matute C. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol. Dis. 2006, 21:154-164.
58. Verkhratsky A., Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007, 13:28-37.
59. Wong R. NMDA receptors expressed in oligodendrocytes. Bioessays 2006, 28:460-464.